References
- Abu-Zhayia, E. R., Khoury-Haddad, H., Guttmann-Raviv, N., Serruya, R., Jarrous, N., & Ayoub, N. (2017). A role of human RNase P subunits, Rpp29 and Rpp21, in homology directed-repair of double-strand breaks. Scientific Reports, 7, 1002. DOI:10.1038/s41598-017-01185-6.
- Ardelt, W., Ardelt, B., & Darzynkiewicz, Z. (2009). Ribonucleases as potential modalities in anticancer therapy. Eur J Pharmacol, 625(1-3), 181-189. https://doi.org/10.1016/j.ejphar.2009.06.067
- Acharya, A., Das, I., Chandhok, D., & Saha, T. (2010). Redox regulation in cancer A double-edged sword with therapeutic potential. Oxidative Medicine and Cellular Longevity, 3(1), 23-34. https://doi.org/10.4161/oxim.3.1.10095
- Babaei, F., Ahmadi, A., Rezaei, F., Jalilvand, S., Ghavami, N., Mahmoudi, M., Abiri, R., Kondori, N., Nategh, R., & Azad, T. M. (2015). Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer. Iran Red Crescent Med J., 17(12), e19439.
- Bettoun, D. J., Scafonas, A., Rutledge, S. J., Hodor, P., Chen, O., Gambone, C., Vogel, R., McElwee-Witmer, S., Bai, C., Freedman, L., & Schmidt, A. (2005). Interaction between the Androgen Receptor and RNase L Mediates a Cross-talk between the Interferon and Androgen Signaling Pathways. THE Journal Of Biological Chemistry, 280(47), 38898-38901. https://doi.org/10.1074/jbc.C500324200
- Cobaleda, C., & Sanchez-Garcia, I. (2000). In vivo inhibition by a site-specific catalytic RNAsubunit of RNase P designed against the BCR-ABL oncogenic products: a novel approach for cancer treatment. BLOOD, 95(3), 731-737 https://doi.org/10.1182/blood.v95.3.731.003k28_731_737
- Court, D. L., Gan, J., Liang, W. H., Shaw, G. X., Tropea, J. E., Costantino, N., Waugh, D. S., & Ji, X. (2013). RNase III Genetics and function structure and mechanism. Annual Review of Genetics, 47, 405-431 https://doi.org/10.1146/annurev-genet-110711-155618
- Dickson, K. A., Haigis, M C., & Raines, R. T. (2005). Ribonuclease Inhibitor: Structure and Function. Prog Nucleic Acid Res Mol Biol., 80, 349-437. https://doi.org/10.1016/S0079-6603(05)80009-1
- Fang, L., Du, W. W., Lyu, J., Dong, J., Zhang, C., Yang, W., He, A., Kwok, Y. S. S., Ma, J., Wu, N., Li, F., Awan, F. M., He, C., Yang, B. L., Peng, C., MacKay, H. J., Yee, A. J., & Yang, B. B. (2018). Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1. Cell Death & Differentiation, 25, 2195-2208. https://doi.org/10.1038/s41418-018-0115-6.
- Fiorini, C., Gotte, G., Donnarumma, F., Picone, D., & Donadelli, M. (2014) Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells. Biochimica et Biophysica Acta, 1843, 976-984. https://doi.org/10.1016/j.bbamcr.2014.01.025
- Gene ID: 11727, Ang angiogenin, ribonuclease, RNase A family, 5 [ Mus musculus (house mouse) ]
- Gill, T., Cai, T., Aulds, J., Wierzbicki, S., & Schmitt, M. E. (2004). RNase MRP Cleaves the CLB2 mRNA To Promote Cell Cycle Progression: Novel Method of mRNA Degradation. Molecular And Cellular Biology, 24(3), 945-953. https://doi.org/10.1128/MCB.24.3.945-953.2004
-
Goparaju, C. M., Blasberg, J. D., Volinia, S., Palatini, J., Ivanov, S., Donington, J. S., Croce, C., Carbone, M., Yang, H., & Pass, H. I. (2011). Onconase mediated NFK
$\beta$ downregulation in malignant pleural mesothelioma. Oncogene, 30(24), 2767-2777. https://doi.org/10.1038/onc.2010.643 - Kim, S., Song, M. L., Min, H., Hwang, I., Baek, S. K., Kwon, T. K., & Park, J. W. (2017). miRNA biogenesis-associated RNase III nucleases Drosha and Dicer are upregulated in colorectal adenocarcinoma. ONCOLOGY LETTERS, 14, 4379-4383. https://doi.org/10.3892/ol.2017.6674
- Kumar, G. R., Chikati, R., Pandrangi, S. L., Kandapal, M., Sonkar, K., Gupta, N., Mulakayala, C., Jagannadham, M. V., Kumar, C. S., Saxena, S., & Das, M. D. (2012). Molecular docking and dynamics simulations of A.niger RNase from Aspergillus niger ATCC26550: for potential prevention of human cancer. J Mol Model. DOI 10.1007/s00894-012-1587-9.
- Lhomond, S., Avril, T., Dejeans, N., Voutetakis, K., Doultsinos, D., McMahon, M., Pineau, R., Obacz, J., Papadodima, O., Jouan, F., Bourien, H., Logotheti, M., Jégou, G., Pallares-Lupon, N., Schmit, K., Le Reste, P. J., Etcheverry, A., Mosser, J., Barroso, K. Vauleon, E., Maurel, M., Samali, A., Patterson, J. B., Pluquet, O., Hetz, C., Quillien, V., Chatziioannou, A., & Chevet, E. (2018). Dual IRE1 RNase functions dictate glioblastoma development. EMBO Molecular Medicine, 10(3), e7929. https://doi.org/10.15252/emmm.201707929
- Li, G., Xiang, Y., Sabapathy, K., & Silverman, R. H. (2004).An Apoptotic Signaling Pathway in the Interferon Antiviral Response Mediated by RNase L and c-Jun NH2-terminal Kinase. The Journal of Biological chemistry, 279(2), 1123-1131. https://doi.org/10.1074/jbc.M305893200
- Liu, Z. C., Cao, K., Xiao, Z. H., Qiao, L., Wang, X. G., Shang, B., Jia, Y., & Wang, Z. (2017). VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma. Oncotarget, 8(39), 65642-65658. https://doi.org/10.18632/oncotarget.20020
- Malathi, K., Paranjape, J. M., Ganapathi, R., & Silverman, R. H. (2004). HPC1/RNASEL Mediates Apoptosis of Prostate Cancer Cells Treated with 2_,5_-Oligoadenylates, Topoisomerase I Inhibitors, and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand. CANCER RESEARCH, 64, 9144-9151. https://doi.org/10.1158/0008-5472.CAN-04-2226
- Miller, D. M., Thomas, S. D., Islam, A., Muench, D., & Sedoris, K. (2012). c-Myc and Cancer Metabolism. Clin Cancer Res., 18(20), 5546-5553. https://doi.org/10.1158/1078-0432.CCR-12-0977
- Mironova, N., Patutina, O., Brenner, E., Kurilshikov, A., Vlassov, V., & Zenkova, M. (2017).The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy. Oncotarget, 8(45), 78796-78810 https://doi.org/10.18632/oncotarget.20228
- Mitkevich, V. A., Tchurikov, N. A., Zelenikhin, P. V., Petrushanko, I. Y., Makarov, A. A., Ilinskaya, O. N. (2010). Binase cleaves cellular noncoding RNAs and affects coding mRNAs. FEBS J, 277(1), 186-196. https://doi.org/10.1111/j.1742-4658.2009.07471.x
- Nicholson, A. W. (2014). Ribonuclease III mechanisms of double-stranded RNA cleavage. WIREs RNA, 5(1), 31-48. doi: 10.1002/wrna.1195.
- Preynat-Seauve, O., Coudurier, S., Favier, A., Marche, P., & Villiers, C. (2003). Oxidative Stress Impairs Intracellular Events Involved in Antigen Processing and Presentation to T Cells. Cell Stress & Chaperones, 8(2), 162-171 https://doi.org/10.1379/1466-1268(2003)008<0162:OSIIEI>2.0.CO;2
- Rybak, S. M., Saxenat, S. K., Ackermant, E. J., & Youle, R. J. (1991). Cytotoxic Potential of Ribonuclease and Ribonuclease Hybrid Proteins. J Biol Chem, 266(31), 21202-21207 https://doi.org/10.1016/S0021-9258(18)54841-9
- Saxena, S. K., Sirdeshmukh, R., Ardelt, W., Mikulski, S. M., Shogen, K., Youle, R. J. (2002). Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family. J Biol Chem, 277(17), 15142-15146. https://doi.org/10.1074/jbc.M108115200
- Wang, X., Yu, H., Sun, W., Kong, J., Zhang, L., Tang, J., Wang, J., Xu, E., Lai, M., & Zhang, H. (2018) The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Molecular Cancer, 17(1), 110 https://doi.org/10.1186/s12943-018-0860-7
- Xie, H., Tang, C. H., Song, J. H., Mancuso, A., Del Valle, J. R., Cao, J., Xiang, Y., Dang, C. V., Lan, R., Sanchez, D. J., Keith, B., Hu, C. C., & Simon, M. C. (2018). IRE1a RNase-dependent lipid homeostasis promotes survival in Myc-transformed cancers. J Clin Invest, 128(4), 1300-1316. https://doi.org/10.1172/JCI95864
- Zhao, H., Ardelt, B., Ardelt, W., Shogen, K., Darzynkiewicz, Z. (2008). The cytotoxic ribonuclease onconase targets RNA interference (siRNA). Cell Cycle, 7(20), 3258-3261. https://doi.org/10.4161/cc.7.20.6855
- Zhao, L., Jha, B. K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., Silverman, R. H., & Weiss, S. R. (2012). Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell Host & Microbe, 11, 607-616. https://doi.org/10.1016/j.chom.2012.04.011
- Zhao, L., Jha, B. K., Wu, A., Elliott, R., Ziebuhr, J., Gorbalenya, A. E., Silverman, R. H., & Weiss, S.R. (2012). Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology. Cell Host Microbe, 11(6), 607-616. https://doi.org/10.1016/j.chom.2012.04.011